Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter

PHASE1TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 26, 2011

Primary Completion Date

June 14, 2012

Study Completion Date

July 16, 2012

Conditions
Venous Thromboembolism
Interventions
DRUG

Apixaban

Trial Locations (14)

1020

Local Institution, Brussels

3000

Local Institution, Leuven

11000

Local Institution, Mexico, D. F.

14080

Local Institution, Mexico City

17033

Penn State Hershey Children'S Hospital, Hershey

43606

The Toledo Children'S Hospital, Toledo

44340

Local Institution, Guadalajara

72190

Local Institution, Puebla City

92868

Children'S Hospital Of Orange County, Orange

08901

Saint Peter'S University Hospital, New Brunswick

T6G 2B7

Local Institution, Edmonton

K1H 8L1

Local Institution, Ottawa

04530

Local Institution, Mexico City

1105 AZ

Local Institution, Amsterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT01195727 - Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter | Biotech Hunter | Biotech Hunter